A61K 38/1883
Neuregulins
Official title: {Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor}
A61K38/1883 (Neuregulins) appears on 101 US grants and 187 published applications in this corpus.
Search patents in A61K- Granted patents
- 101
- Published applications
- 187
- Assignees
- 76
- Inventors
- 205
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 4 |
| 2003 | 2 | 1 |
| 2004 | 0 | 2 |
| 2005 | 2 | 3 |
| 2006 | 3 | 5 |
| 2007 | 1 | 5 |
| 2008 | 1 | 2 |
| 2009 | 1 | 3 |
| 2010 | 2 | 7 |
| 2011 | 2 | 9 |
| 2012 | 2 | 4 |
| 2013 | 3 | 10 |
| 2014 | 7 | 14 |
| 2015 | 8 | 12 |
| 2016 | 5 | 18 |
| 2017 | 6 | 11 |
| 2018 | 5 | 13 |
| 2019 | 7 | 7 |
| 2020 | 10 | 11 |
| 2021 | 6 | 8 |
| 2022 | 5 | 14 |
| 2023 | 4 | 4 |
| 2024 | 6 | 7 |
| 2025 | 4 | 9 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for treating heart failure18 Aug 2026US 12,708,658 B2Zensun (Shanghai) Science & Technology, Co., Ltd.
- Method for preventing, treating or delaying myocardial damage using neuregulin and composition4 Aug 2026US 12,697,371 B2Zensun (Shanghai) Science & Technology, Co., Ltd.
- Method and kit for treating a neurodegenerative disease11 Nov 2025US 12,466,865 B2The Board of Trustees of the University of Illinois
- Inducing proliferation of cardiomyocytes and therapeutic uses related thereto13 May 2025US 12,295,930 B2Emory University
- Method of effecting neuroprotection using soluble neuregulin isoforms18 Mar 2025US 12,251,423 B2Mind-NRG Sàrl
- Neuregulin and use thereof16 Apr 2026US 2026/0103496 A1Zensun (Shanghai) Science & Technology, Co., Ltd.
- Methods and compositions for treating cancer26 Feb 2026US 2026/0053891 A1The Regents of the University of Michigan
- Methods and devices for promoting nerve growth and regeneration29 Jan 2026US 2026/0027184 A1
- Inducing Proliferation of Cardiomyocytes and Therapeutic Uses Related Thereto4 Dec 2025US 2025/0367152 A1Emory University
- Extended release of neuregulin for treating heart failure27 Nov 2025US 2025/0360078 A1Zensun (Shanghai) Science & Technology, Co., Ltd.
Most cited
By later US patents
- Device for delivery of substances and methods of use thereof99US 5,681,568 ACambridge NeuroScience, Inc. · 1997
- In vivo genetic modification of growth factor-responsive neural precursor cells96US 6,071,889 ANeurospheres Holdings Ltd. · 2000
- Cardiac muscle function and manipulation55US 7,226,907 B1Zensun (Shanghai) Science & Technology, Co., Ltd. · 2007
- Methods for treating congestive heart failure52US 6,635,249 B1CeNes Pharmaceuticals, Inc. · 2003
- Cardiac muscle function and manipulation42US 7,612,164 B2Zensun (Shanghai) Science and Technologies Ltd. · 2009